COMMUNIQUÉS West-GlobeNewswire

HepatoBurn Reviews: The Mysterious Red Phenol Formula for Metabolism Support

17/04/2025 - 05:27

Clinically-Inspired Red Phenol Formula Targets Stubborn Fat, Hormonal Imbalance, and Sluggish Metabolism in Adults Over 35 Without Stimulants or Crash Diets Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) -- [...]

Java Burn Under Review - The Best Healthy Coffee Option for Weight Managementcument

17/04/2025 - 05:47

Clinically-Inspired Thermogenic Formula Enhances Metabolism, Burns Fat, and Elevates Energy — Java Burn Emerges as the #1 Healthy Coffee Additive for Sustainable Weight Management in 2025 Albany, New York, April 16, [...]

Teladoc Health to Announce First Quarter 2025 Financial Results

17/04/2025 - 00:00

PURCHASE, NY, April 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the [...]

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

16/04/2025 - 20:12

Gloperba ® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Pericarditis is an inflammation of the pericardium, the sac-like [...]

Eascra Biotech Preparing for a Fifth Flight to the International Space Station

16/04/2025 - 21:30

The nanotech startup’s research will be aboard SpaceX 32 when it launches Mon, April 21 BOSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech research will be aboard SpaceX 32, scheduled to launch in April, [...]

Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)

16/04/2025 - 22:04

Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or elevated risk of chikungunya. COPENHAGEN, Denmark, April 16, 2025 – Bavarian [...]

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025

16/04/2025 - 22:05

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first [...]

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires

16/04/2025 - 22:05

BOSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

16/04/2025 - 22:05

BRISBANE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16/04/2025 - 22:05

CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore [...]

Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

16/04/2025 - 22:32

SAN JOSE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]

Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease

16/04/2025 - 22:44

BUENOS AIRES, Argentina, April 16, 2025 (GLOBE NEWSWIRE) -- Biosidus , an Argentinean pioneer company in biotechnology research, development, and the production of high-quality biosimilars, has announced encouraging [...]

FOXO TECHNOLOGIES INC. ANNOUNCES FILING OF ITS ANNUAL REPORT ON FORM 10-K

16/04/2025 - 23:45

WEST PALM BEACH, FL, April 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”) announces that it has filed its Annual Report on Form 10-K on April 15, 2025. Pursuant to the [...]

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress dont une présentation sur son vaccin contre le chikungunya IXCHIQ®

16/04/2025 - 17:45

Saint-Herblain (France), le 16 avril 2025 - Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui sa présence au 25ème World Vaccine Congress, qui se tiendra du 21 [...]

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

16/04/2025 - 17:45

Saint-Herblain (France), April 16, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place [...]

Correction: Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l’exercice 2025

16/04/2025 - 18:36

ERRATUM – ANNULE ET REMPLACE Nous regrettons une erreur dans le tableau inclus dans le communiqué de presse en français. Merci de le remplacer par celui-ci. Croissance des ventes de 11,6% à taux de change constant 1 , [...]

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

16/04/2025 - 18:45

CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]

SPINEWAY : Chiffre d’affaires du 1er trimestre 2025 de 2,8 M€

16/04/2025 - 19:00

Communiqué de presse Ecully, le 16 avril 2025 – 19h SPINEWAY Chiffre d’affaires du 1 er trimestre 2025 de 2,8 M€ En milliers d’euros 2025 2024 Variation en % CA 1 er trimestre 2 828 3 070 - 8% Données consolidées non [...]

Spineway : First-quarter 2025 revenue of €2.8 million

16/04/2025 - 19:10

Press release Ecully, April 16, 2025 – 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros 2025 2024 Change as a % Q1 revenue 2,828 3,070 -8% Unaudited consolidated data Spineway, a [...]